Lumea: Enabling pathologists to use cutting-edge diagnostic solutions for decision support in Gleason grading prostate cancer specimens. LEHI, UTAH, USA, December 7, 2023 /EINPresswire.com/ -- Lumea Inc., a leader in integrated digital...

Roche’s navify Digital Pathology software platform now offers Ibex’s Artificial Intelligence (AI) algorithms to support clinicians in the diagnosis of breast and prostate cancer. Roche and Ibex cloud-based digital...

Paige Lymph Node is recognized by the FDA as a breakthrough device to assist pathologists in the detection of breast cancer metastases in lymph node tissue NEW YORK--(BUSINESS WIRE)--Paige, a global leader in end-to-end digital...

Ibex: Developed in Collaboration with AstraZeneca and Daiichi Sankyo, Galen™ Breast HER2 Aids Pathologists with Reproducible HER2 Assessment  TEL AVIV, Israel, Sept. 7, 2023 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in...

Monday, September 11, 2023 - The University of Limerick’s Digital Cancer Research Centre and Dell Technologies (NYSE:DELL) have joined forces with to develop an artificial intelligence (AI) platform and digital twin technology to power...

Microsoft is teaming up with the company Paige to build the world’s largest image-based artificial intelligence model for identifying cancer. Paige develops AI-powered solutions for pathologists, which are the kind of doctors who...